Unichem Laboratories (NSE:UNICHEMLAB) Stock Based Compensation: ₹0 Mil (TTM As of Mar. 2026)


NSE:UNICHEMLAB Unichem Laboratories Ltd NSE:UNICHEMLAB
66 GF Score
Price ₹477.25
GF Value ₹690.65
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Unichem Laboratories Stock Based Compensation?

Unichem Laboratories NSE:UNICHEMLAB +3.11% 66 Stock Based Compensation is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:UNICHEMLAB with a GF Score™ of 66/100 and a GF Value™ of ₹690.65 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Unichem Laboratories's Stock Based Compensation for the three months ended in Mar. 2026 was ₹0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Unichem Laboratories Stock Based Compensation Related Terms

Unichem Laboratories Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Unichem Laboratories's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unichem Laboratories Stock Based Compensation Chart

Unichem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.48 10.49 30.80 21.20 8.10

Unichem Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:UNICHEMLAB
66GF Score
Unichem Laboratories Ltd NSE:UNICHEMLAB
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unichem Laboratories Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

What does a Stock Based Compensation of ₹0 Mil mean?
Unichem Laboratories (NSE:UNICHEMLAB) has a Stock Based Compensation of ₹0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Unichem Laboratories and its competitors.
Is Unichem Laboratories' Stock Based Compensation too high?
Unichem Laboratories' current Stock Based Compensation is ₹0 Mil. Overall, Unichem Laboratories has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Unichem Laboratories' Stock Based Compensation compare to ZTS and UTHR?
Unichem Laboratories' Stock Based Compensation of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Unichem Laboratories and its competitors. Unichem Laboratories's current Stock Based Compensation is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unichem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Unichem Laboratories (NSE:UNICHEMLAB) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹690.65, compared to a current price of ₹477.25 — trading 30.9% below its estimated fair value. The current Stock Based Compensation is ₹0 Mil. Unichem Laboratories' overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Unichem Laboratories (NSE:UNICHEMLAB), the current Stock Based Compensation is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued. The current stock price of ₹477.25 is trading 30.9% below its estimated GF Value™ of ₹690.65. GuruFocus considers Unichem Laboratories to be Significantly Undervalued.

Key valuation signals for NSE:UNICHEMLAB:

  • Stock Based Compensation: ₹0 Mil
  • GF Value™: ₹690.65 vs. price of ₹477.25 (30.9% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unichem Laboratories Business Description

Other Exchanges 506690:India
Address Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
66GF Score

Get the complete analysis for NSE:UNICHEMLAB

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹477.25
Price
₹690.65
GF Value